Search research articles
Contact Us
Filters
Showing results (141-150 of 224) with videos related to
Page
of 23
Sort By:
British Journal of Cancer
|
May 20, 2004
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients
J-L Pujol, O Molinier, W Ebert, et al.
Cancer Detection and Prevention
|
January 1, 1981
A cooperative study on the detection of colorectal cancer and polyps in France
F Martin, T Poynard, A Ribet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
H Bonnefoi, T Grellety, O Tredan, et al.
ESMO Open
|
April 16, 2025
Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial
M Saint-Ghislain, S Chabaud, F Dalenc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2018
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
P Cottu, V D'Hondt, S Dureau, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics
|
April 7, 2010
X-ray polarization spectroscopy to study anisotropic velocity distribution of hot electrons produced by an ultra-high-intensity laser
Y Inubushi, Y Okano, H Nishimura, et al.
Oncogene
|
March 16, 2023
Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program
D Bello Roufai, A Gonçalves, T De La Motte Rouge, et al.
Oncogene
|
January 7, 2023
Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program
D Bello Roufai, A Gonçalves, T De La Motte Rouge, et al.
Haematologica
|
March 26, 2026
Extracellular vesicles from aged individuals trigger mitochondrial dysfunction in haematopoietic progenitor cells
Isabelle J Grenier-Pleau, Jasleen Kaur, Christopher J Wells, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2024
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial
P Harter, C Marth, M-A Mouret-Reynier, et al.
Page
of 23
Search research articles
Search
Showing results (141-150 of 224) with videos related to
Sort By:
Page
of 23
British Journal of Cancer
|
May 20, 2004
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients
J-L Pujol, O Molinier, W Ebert, et al.
Cancer Detection and Prevention
|
January 1, 1981
A cooperative study on the detection of colorectal cancer and polyps in France
F Martin, T Poynard, A Ribet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
H Bonnefoi, T Grellety, O Tredan, et al.
ESMO Open
|
April 16, 2025
Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial
M Saint-Ghislain, S Chabaud, F Dalenc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2018
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
P Cottu, V D'Hondt, S Dureau, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics
|
April 7, 2010
X-ray polarization spectroscopy to study anisotropic velocity distribution of hot electrons produced by an ultra-high-intensity laser
Y Inubushi, Y Okano, H Nishimura, et al.
Oncogene
|
March 16, 2023
Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program
D Bello Roufai, A Gonçalves, T De La Motte Rouge, et al.
Oncogene
|
January 7, 2023
Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program
D Bello Roufai, A Gonçalves, T De La Motte Rouge, et al.
Haematologica
|
March 26, 2026
Extracellular vesicles from aged individuals trigger mitochondrial dysfunction in haematopoietic progenitor cells
Isabelle J Grenier-Pleau, Jasleen Kaur, Christopher J Wells, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2024
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial
P Harter, C Marth, M-A Mouret-Reynier, et al.
Page
of 23